(openPR) - Internationally renowned, contract research organisation Onyx Scientific, is pleased to announce the continued growth of its small-scale GMP custom synthesis services for development APIs (Active Pharmaceutical Ingredients)
Commenting on the growing success of its small-scale GMP synthesis services, CEO, Dr Tony Flinn says “our success is due to open communication and a highly responsive scientific team, who are able to lower the cost of a GMP process by suggesting alternative chemical pathways to develop an API product”.
Denise Bowser, Commercial Director, Onyx Scientific adds, “Newly patented APIs are driving the demand for quality GMP compliance and it’s here we excel, in streamlining GMP-approved processes and difficult-to-synthesise APIs. Our compliance standards minimise impurities, reduce costs and significantly improve timelines for phase I and II clinical studies.
Denise adds. “Onyx has earned the enviable reputation as one of the hardest working chemistry service providers with world-class GMP synthesis capability to harmonise:
Communications protocols
Selection of the starting materials
Mapping of critical manufacturing steps
Process parameters and controls for product quality
Capacity to reduce or remove impurities
Assessment of process robustness
Proof that methods are suitable for validation and scale up
Identification and control of critical intermediates
Certificates of analysis
Onyx Scientific’s GMP kilo-lab facility boasts flexible isolation rooms, a class 100,000 clean-room and a variety of vessel sizes up to 100 litres enabling ultimate technology transfer to manufacturing scale and access to an extensive range of analytical services with expert GMP regulatory guidance provided as standard”.
In addition to GMP synthesis and scale-up, Onyx Scientific’s breath of services include solid-form polymorph screening, salt selection, custom synthesis, process development and lead optimisation.
The Onyx Scientific service model provides both dedicated FTE and fee-for-service resources, with full transparency and flexibility to switch resource on and off as needed even at short notice
MHRA certified, Onyx Scientific’s state-of-the-art facility conforms to international GMP standards for the development and production of active pharmaceutical ingredients.
Among the first of its type to be approved by the UK Medicines and Healthcare Products Regulatory Agency (MHRA, equivalent to the US FDA), Onyx Scientific’s breath of services include: GMP synthesis, solid-form polymorph screening, salt selection, custom synthesis, process development and lead optimisation.
Onyx Scientific Ltd
Silverbriar
Enterprise Park East
Sunderland
UK
Sue Jones
Tel: +44 (0) 191 516 6516 www.onyx-scientific.com
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
Newsfeed
